摘要
乳腺癌新辅助治疗是局部晚期乳腺癌和可手术乳腺癌的重要治疗方式。乳腺癌新辅助临床诊治尽管已取得很多进展,但仍然面临诸多争议,有必要对乳腺癌的新辅助治疗形成共识。在结合2018年的共识投票基础上,综合新辅助诊治的研究结果,浙江省医学会外科学分会和浙江省医师协会乳腺肿瘤专业委员会联合发布《浙江省乳腺癌新辅助治疗专家共识(2018)》。共识结合了理论与实践,针对乳腺癌新辅助治疗的适应证与意义、新辅助治疗的评估、新辅助治疗的方案和新辅助治疗完成后的局部区域治疗四个方面进行原则性总结并详细阐释,同时附以共识投票结果,以期更好地指导乳腺癌的新辅助临床诊治。
Neoadjuvant therapy is important for both locally advanced and operable breast cancer.Although there have been a lot of progress in neoadjuvant treatment,but still many controversies exist.It is necessary to form a principled and standardized consensus on breast cancer neoadjuvant treatment.In order to better guide and regulate the neoadjuvant clinical diagnosis and treatment of breast cancer,Zhejiang Society of Surgery,Zhejiang Medical Association and Breast Tumor Professional Committee,Zhejiang Medical Doctors Association jointly established'Expert Consensus on Neoadjuvant Therapy for Breast Cancer in Zhejiang Province(2018)',based on the consensus of the vote in 2018 and research results of neoadjuvant treatments.The consensus combines theory and practice,summarizes and elaborates in principle the indications and significance of neoadjuvant therapy for breast cancer,the evaluation of neoadjuvant therapy,the neoadjuvant therapy scheme and the local regional treatment after the completion of neoadjuvant therapy.Meanwhile,the consensus voting result is attached.
作者
浙江省医学会外科学分会
浙江省医师协会乳腺肿瘤专业委员会
杨红健
俞星飞
Zhejiang Society of Surgery,Zhejiang Medical Association;Breast Tumor Professional Committee,Zhejiang Medical Doctors Association
出处
《肿瘤学杂志》
CAS
2019年第4期277-292,共16页
Journal of Chinese Oncology
关键词
乳腺肿瘤/治疗
新辅助
卫生信息管理
,breast neoplasm/therapy,neoadjuvant
health information management
